Corticotropin-releasing factor-related peptides, serotonergic systems, and emotional behavior

被引:73
作者
Fox, James H. [1 ]
Lowry, Christopher A.
机构
[1] Univ Colorado, Dept Integrat Physiol, Behav Neuroendocrinol Lab, 1725 Pleasant St, Boulder, CO 80309 USA
基金
美国国家科学基金会;
关键词
anxiety; corticotropin-releasing factor; dorsal raphe nucleus; emotional behavior; serotonin; DORSAL RAPHE NUCLEUS; MESSENGER-RNA EXPRESSION; EDINGER-WESTPHAL NUCLEUS; MEDIAL PREFRONTAL CORTEX; IMPAIRED STRESS-RESPONSE; C-FOS EXPRESSION; TOPOGRAPHICALLY ORGANIZED SUBPOPULATIONS; INDUCED REPRODUCTIVE DYSFUNCTION; CENTRAL-NERVOUS-SYSTEM; ANXIETY-LIKE BEHAVIOR;
D O I
10.3389/fnins.2013.00169
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Corticotropin-releasing factor (CRF) is a 41-amino acid neuropeptide that is involved in stress-related physiology and behavior, including control of the hypothalamic-pituitary-adrenal (HPA) axis. Members of the CRF family of neuropeptides, including urocortin 1 (UCN 1), UCN 2, and UCN 3, bind to the G protein-coupled receptors, CRF type 1 (CRF1) and CRF2 receptors. In addition, CRF binding protein (CRFBP) binds both CRF and UCN 1 and can modulate their activities. There are multiple mechanisms through which CRF-related peptides may influence emotional behavior, one of which is through altering the activity of brainstem neuromodulatory systems, including serotonergic systems. CRF and CRF-related peptides act within the dorsal raphe nucleus (DR), the major source for serotonin (5-HT) in the brain, to alter the neuronal activity of specific subsets of serotonergic neurons and to influence stress-related behavior. CRF-containing axonal fibers innervate the DR in a topographically organized manner, which may contribute to the ability of CRF to alter the activity of specific subsets of serotonergic neurons. CRF and CRF-related peptides can either increase or decrease serotonergic neuronal firing rates and serotonin release, depending on their concentrations and on the specific CRF receptor subtype(s) involved. This review aims to describe the interactions between CRF-related peptides and serotonergic systems, the consequences for stress-related behavior, and implications for vulnerability to anxiety and affective disorders.
引用
收藏
页数:16
相关论文
共 202 条
[61]   Early life experience alters behavior during social defeat: Focus on serotonergic systems [J].
Gardner, KL ;
Thrivikraman, KV ;
Lightman, SL ;
Plotsky, PM ;
Lowry, CA .
NEUROSCIENCE, 2005, 136 (01) :181-191
[62]   Benefits From Antidepressants Synthesis of 6-Week Patient-Level Outcomes From Double-blind Placebo-Controlled Randomized Trials of Fluoxetine and Venlafaxine [J].
Gibbons, Robert D. ;
Hur, Kwan ;
Brown, C. Hendricks ;
Davis, John M. ;
Mann, J. John .
ARCHIVES OF GENERAL PSYCHIATRY, 2012, 69 (06) :572-579
[63]   Acute panic inventory symptoms during CO2 inhalation and room-air hyperventilation among panic disorder patients and normal controls [J].
Goetz, RR ;
Klein, DF ;
Papp, LA ;
Martinez, JM ;
Gorman, JM .
DEPRESSION AND ANXIETY, 2001, 14 (02) :123-136
[64]   Selective serotonin reuptake inhibitors in the treatment of affective disorders - III. Tolerability, safety and pharmacoeconomics [J].
Goldstein, BJ ;
Goodnick, PJ .
JOURNAL OF PSYCHOPHARMACOLOGY, 1998, 12 (03) :S55-S87
[65]   AMYGDALOID CRF PATHWAYS - ROLE IN AUTONOMIC, NEUROENDOCRINE, AND BEHAVIORAL-RESPONSES TO STRESS [J].
GRAY, TS .
CORTICOTROPIN-RELEASING FACTOR AND CYTOKINES: ROLE IN THE STRESS RESPONSE: HANS SELYE SYMPOSIUM ON NEUROENDOCRINOLOGY AND STRESS, 1993, 697 :53-60
[66]   5-HT2C Receptors in the Basolateral Amygdala and Dorsal Striatum Are a Novel Target for the Anxiolytic and Antidepressant Effects of Exercise [J].
Greenwood, Benjamin N. ;
Strong, Paul V. ;
Loughridge, Alice B. ;
Day, Heidi E. W. ;
Clark, Peter J. ;
Mika, Agnieszka ;
Hellwinkel, Justin E. ;
Spence, Katie G. ;
Fleshner, Monika .
PLOS ONE, 2012, 7 (09)
[67]   Wheel running alters serotonin (5-HT) transporter, 5-HT1A, 5-HT1B, and alphal1b-adrenergic receptor mRNA in the rat raphe nuclei [J].
Greenwood, BN ;
Foley, TE ;
Day, HEW ;
Burhans, D ;
Brooks, L ;
Campeau, S ;
Fleshner, M .
BIOLOGICAL PSYCHIATRY, 2005, 57 (05) :559-568
[68]  
Greenwood BN, 2003, J NEUROSCI, V23, P2889
[69]  
Grove E. A., 1998, J COMP NEUROL, V15, P35
[70]   PRESYNAPTIC 5-HT1B RECEPTOR-MEDIATED SEROTONERGIC INHIBITION OF GLUTAMATE TRANSMISSION IN THE BED NUCLEUS OF THE STRIA TERMINALIS [J].
Guo, J. -D. ;
Rainnie, D. G. .
NEUROSCIENCE, 2010, 165 (04) :1390-1401